Wilmington-based Predicate AI Labs Inc. has entered a collaboration with the Mayo Clinic to advance the early detection of sepsis, the leading cause of mortality worldwide. The healthcare technology company is developing a predictive artificial intelligence platform that can quickly identify critical illness, with an initial focus on sepsis. Predicate's OpenDx platform uses real-time physiological data from a wearable sensor, show on one of the clinical study patients in Accra, Ghana. Information from the wearable is combined with advanced AI models to detect early patterns that may signal sepsis risk. According to Nguyen, working with the Mayo Clinic will help ensure that OpenDx can identify meaningful signals of sepsis earlier, when clinical actions will have the greatest impact.